Andrew Grigg

Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations.

Doen Ming Ong, Michael Ashby, Andrew Grigg, Grace Gard, Zi Y Ng, Huayi Ellen Huang, Yee Shuen Chong, Chan Yoon Cheah, Bianca Devitt, Geoffrey Chong, Zoe Loh, Allison Mo, Eliza A Hawkes

Journal article  |  2019  |  British Journal of Haematology

Elderly patients may be heterogeneous in their abilities to tolerate immunochemotherapy-associated toxicities. We describe the mor..

Management of Patients With Erythropoietic Protoporphyria-Related Progressive Liver Disease

Zaid S Ardalan, Sujievvan Chandran, Abhinav Vasudevan, Peter W Angus, Andrew Grigg, Simon He, Graeme A Macdonald, Simone I Strasser, Courtney J Tate, Glen A Kennedy, Adam G Testro, Paul J Gow

Journal article  |  2019  |  Liver Transplantation

THE MANY FACES OF FAMILIAL HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS

Ilia Voskoboinik, Paul Gray, Stephen Opat, Andrew Grigg, Anthony Jaworowski, Joseph Trapani

Conference Proceedings  |  2019  |  INTERNAL MEDICINE JOURNAL

New Advances in the Management of Cytomegalovirus in Allogeneic Haemopoietic Stem Cell Transplantation.

Michelle K Yong, David Gottlieb, Julian Lindsay, Jen Kok, William Rawlinson, Monica Slavin, David Ritchie, Ashish Bajel, Andrew Grigg

Journal article  |  2019  |  Internal Medicine Journal

Cytomegalovirus (CMV) viremia continues to be a frequent complication in the post haemopoietic stem cell transplant (HSCT) period ..

Nivolumab induces dynamic alterations in CD8 T-cell function and TIM-3 expression when used to treat relapsed acute myeloid leukemia after allogeneic stem cell transplantation

Eric Wong, Joanne Davis, Rachel Koldej, Jeff Szer, Andrew Grigg, David Ritchie

Journal article  |  2019  |  Leukemia & Lymphoma

Screening and Prophylaxis to Prevent Hepatitis B Reactivation Other Populations and Newer Agents

Joe Sasadeusz, Andrew Grigg, Peter D Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G Gish, Kumar Visvanathan

Journal article  |  2019  |  Clinics in Liver Disease

Because of the relatively high prevalence of both hepatitis B infection and various forms of autoimmune inflammatory diseases trea..

Screening and Prophylaxis to Prevent Hepatitis B Reactivation Introduction and Immunology

Joe Sasadeusz, Andrew Grigg, Peter D Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G Gish, Kumar Visvanathan

Journal article  |  2019  |  Clinics in Liver Disease

Current recommendations concerning hepatitis C virus (HBV) reactivation are limited, with nearly all guidelines focused on its occ..

Screening and Prophylaxis to Prevent Hepatitis B Reactivation Transplant Recipients

Joe Sasadeusz, Andrew Grigg, Peter D Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G Gish, Kumar Visvanathan

Journal article  |  2019  |  Clinics in Liver Disease

Organ transplantation is a lifesaving procedure for many patients. To prevent rejection or graft-versus-host disease, recipients r..

Screening and Prophylaxis to Prevent Hepatitis B Reactivation Patients with Hematological and Solid Tumor Malignancies

Joe Sasadeusz, Andrew Grigg, Peter D Hughes, Seng Lee Lim, Michaela Lucas, Geoff McColl, Sue Anne McLachlan, Marion G Peters, Nicholas Shackel, Monica Slavin, Vijaya Sundararajan, Alexander Thompson, Joseph Doyle, James Rickard, Peter De Cruz, Robert G Gish, Kumar Visvanathan

Journal article  |  2019  |  Clinics in Liver Disease

Patients with malignancies require chemotherapy and other immunosuppressive therapies for treatment. Because of this immunosuppres..

Effect of Recombinant Zoster Vaccine on Incidence of Herpes Zoster After Autologous Stem Cell Transplantation A Randomized Clinical Trial

Adriana Bastidas, Javier de la Serna, Mohamed El Idrissi, Lidia Oostvogels, Philippe Quittet, Javier Lopez-Jimenez, Filiz Vural, David Pohlreich, Tsila Zuckerman, Nicolas C Issa, Gianluca Gaidano, Je-Jung Lee, Sunil Abhyankar, Carlos Solano, Jaime Perez de Oteyza, Michael J Satlin, Stefan Schwartz, Magda Campins, Alberto Rocci, Carlos Vallejo Llamas, et al.

Journal article  |  2019  |  JAMA

The effect of tyrosine kinase inhibitor interruption and interferon use on pregnancy outcomes and long-term disease control in chronic myeloid leukemia

Masa Lasica, Abbey Willcox, Kate Burbury, David M Ross, Susan Branford, Jason Butler, Robin Filshie, Henry Januszewicz, David Joske, Anthony Mills, David Simpson, Constantine Tam, Kerry Taylor, Anne-Marie Watson, Max Wolf, Andrew Grigg

Journal article  |  2019  |  Leukemia & Lymphoma

The management of CML in pregnancy is challenging with the need to balance disease control against potential teratogenic effects o..

Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression

John F Seymour, Robert Marcus, Andrew Davies, Eve Gallop-Evans, Andrew Grigg, Andrew Haynes, Michael Herold, Thomas Illmer, Herman Nilsson-Ehle, Martin Soekler, Ulrich Duenzinger, Tina Nielsen, Aino Launonen, Wolfgang Hiddemann

Journal article  |  2019  |  Haematologica

Ability of routine blood tests (RBTs) in asymptomatic patients (pts) with indolent non-Hodgkin lymphoma (iNHL) to detect relapse or clinically significant disease progression.

Oliver Piercey, Zoe Loh, Joanna Chan, Geoffrey Chong, Andrew Grigg, Steven Cheema, Tania Cushion, Gurjot Gill, Matthew Whybird, Eliza Anne Hawkes

Conference Proceedings  |  2019  |  JOURNAL OF CLINICAL ONCOLOGY

Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients

Sam E Grigg, Patrick Date, Zoe Loh, Ortis Estacio, Douglas F Johnson, Eliza A Hawkes, Andrew Grigg

Journal article  |  2019  |  Supportive Care in Cancer

Strategies to enhance the graft versus tumour effect after allogeneic haematopoietic stem cell transplantation

Eric Wong, Joanne E Davis, Andrew Grigg, Jeff Szer, David Ritchie

Journal article  |  2019  |  Bone Marrow Transplantation

Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cells

David M Ross, Ilaria S Pagani, Naranie Shanmuganathan, Chung H Kok, John F Seymour, Anthony K Mills, Robin J Filshie, Christopher K Arthur, Dang Phuong, Verity A Saunders, Jodi Braley, Agnes S Yong, David T Yeung, Deborah L White, Andrew P Grigg, Anthony P Schwarer, Susan Branford, Timothy P Hughes

Journal article  |  2018  |  Leukemia

The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients

Abbey Willcox, Eric Wong, Christa Nath, Brett Janson, Simon J Harrison, Rosemary Hoyt, Ashish Bajel, Peter Shaw, David Ritchie, Andrew Grigg

Journal article  |  2018  |  Annals of Hematology

Combination of Nilotinib and Pegylated Interferon Alfa-2b Results in High Molecular Response Rates in Chronic Phase CML: Interim Results of the ALLG CML 11 Pinnacle Study

David T Yeung, Andrew P Grigg, Naranie Shanmuganathan, Ilona Cunningham, Jake Shortt, Philip Rowling, John Reynolds, Rachel Cushion, Rosemary Anne Harrup, David M Ross, David Kipp, Anthony K Mills, Christopher K Arthur, Anthony P Schwarer, Kathryn Jackson, Nicholas Viiala, Robert Weinkove, Agnes SM Yong, Deborah L White, Susan Branford, et al.

Conference Proceedings  |  2018  |  Blood

A Novel Prognostic Model That Is Superior to FLIPI-1 and FLIPI-2 and Integrated Clinical and Treatments Factors to Predict Progression-Free Survival and Early Treatment Failure in Patients with Follicular Lymphoma in the GALLIUM Trial

Farheen Mir, Andrew Grigg, Michael Herold, Wolfgang Hiddemann, Robert Marcus, John F Seymour, Christopher R Bolen, Andrea Knapp, Aino Launonen, Federico Mattiello, Tina Nielsen, Mikkel Z Oestergaard, Michael Wenger, Carla Casulo

Conference Proceedings  |  2018  |  Blood

An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma

Joel C Wight, Eliza A Hawkes, Salvatore U Berlangieri, Richard Khor, Andrew P Grigg

Journal article  |  2018  |  Leukemia & Lymphoma

Peripheral blood stem cell mobilisation with G-CSF alone versus G-CSF and cyclophosphamide after bortezomib, cyclophosphamide and dexamethasone induction in multiple myeloma

Chong Chyn Chua, Hui Yin Lim, Khai Li Chai, Jeremy Ong, Shirlene Sim, Colin Wood, Michael Dickinson, Philip Campbell, Jennifer Hempton, Hayley King, Claire Dowsing, Krystal Bergin, Sharon Muir, Simon Gibbs, Andrew Grigg

Journal article  |  2018  |  Bone Marrow Transplantation

Management of Pregnancy in Women With Chronic Myeloid Leukemia

David M Ross, Kate L Burbury, Andrew P Grigg, Timothy P Hughes, John F Seymour

Journal article  |  2018  |  Journal of Clinical Oncology

Echocardiography has low utility in cancer patients with Staphylococcus aureus bacteraemia: findings from a retrospective study

Zoe Loh, Ortis Estacio, Andrew Grigg, Natasha E Holmes, Geoff Chong, Eliza A Hawkes

Journal article  |  2018  |  Supportive Care in Cancer

Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI

Joel C Wight, Geoffrey Chong, Andrew P Grigg, Eliza A Hawkes

Journal article  |  2018  |  Blood Reviews

Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission

Eliza A Hawkes, Zoe Loh, Ortis Estacio, Geoff Chong, Francis J Ha, Michael Gilbertson, Andrew Grigg

Journal article  |  2018  |  British Journal of Cancer

Prognostic markers in core-binding factor AML and improved survival with multiple consolidation cycles of intermediate-/high-dose cytarabine

Ashvind Prabahran, Mark Tacey, Shaun Fleming, Andrew Wei, Courtney Tate, Paula Marlton, Joel Wight, Andrew Grigg, Annabel Tuckfield, Jeff Szer, David Ritchie, Lynette Chee

Journal article  |  2018  |  European Journal of Haematology

Limited utility of routine chest X-ray in initial evaluation of neutropenic fever in patients with haematological diseases undergoing chemotherapy

Ortis Estacio, Zoe Loh, Amy Baker, Geoff Chong, Andrew Grigg, Leonid Churilov, Eliza A Hawkes

Journal article  |  2018  |  Internal Medicine Journal

Bi-Allelic Mutations in STXBP2 Reveal a Complementary Role for STXBP1 in Cytotoxic Lymphocyte Killing

Jamie A Lopez, Tahereh Noori, Adrian Minson, Lu Li Jovanoska, Kevin Thia, Michael S Hildebrand, Hedieh Akhlaghi, Phillip K Darcy, Michael H Kershaw, Natasha J Brown, Andrew Grigg, Joseph A Trapani, Ilia Voskoboinik

Journal article  |  2018  |  Frontiers in Immunology

Long-Term Follow-up of the ALLG CML8 Twister Study of Treatment-Free Remission (TFR) in Patients with Chronic Myeloid Leukemia (CML)

David M Ross, Ilaria S Pagani, Naranie Shanmuganathan, John F Seymour, Anthony K Mills, Robin J Filshie, Christopher K Arthur, Dang Phuong, Verity A Saunders, Jody Braley, David T Yeung, Deborah L White, Andrew P Grigg, Anthony P Schwarer, Susan Branford, Timothy P Hughes

Conference Proceedings  |  2017  |  BLOOD

Early radiological intervention and haematology screening is associated with excellent outcomes in Budd-Chiari syndrome

Allison Mo, Adam Testro, Janine French, Marcus Robertson, Peter Angus, Andrew Grigg

Journal article  |  2017  |  Internal Medicine Journal

An individualised risk-adapted protocol of pre-and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: results of a phase II prospective trial

A Grigg, B Butcher, B Khodr, A Bajel, M Hertzberg, S Patil, AB D'Souza, P Ganly, P Ebeling, E Wong

Journal article  |  2017  |  Bone Marrow Transplantation

The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia

Lucy C Fox, Katherine D Cummins, Ben Costello, David Yeung, Rebecca Cleary, Cecily Forsyth, Maciek Tatarczuch, Kate Burbury, Olga Motorna, Jake Shortt, Shaun Fleming, Andrew McQuillan, Anthony Schwarer, Rosemary Harrup, Amy Holmes, Sumita Ratnasingam, Kah-Lok Chan, Wei-Hsun Hsu, Asma Ashraf, Faye Putt, et al.

Journal article  |  2017  |  Blood Advances

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia

Kenneth F Bradstock, Emma Link, Juliana Di Iulio, Jeff Szer, Paula Marlton, Andrew H Wei, Arno Enno, Anthony Schwarer, Ian D Lewis, James D'Rozario, Luke Coyle, Gavin Cull, Phillip Campbell, Michael F Leahy, Uwe Hahn, Paul Cannell, Campbell Tiley, Ray M Lowenthal, John Moore, Kimberly Cartwright, et al.

Journal article  |  2017  |  Journal of Clinical Oncology

Early Treatment Intensification With R-ICE And 90Y-Ibritumomab Tiuxetan (Zevalin)-BEAM Stem Cell Transplantation In Patients With High Risk Diffuse Large B-Cell Lymphoma Patients And Positive Interim PET After 4 Cycles Of R-CHOP-14

Mark Hertzberg, Maher K Gandhi, Judith Trotman, Belinda Butcher, John Taper, Amanda Johnston, Devinder Gill, Shir-Jing Ho, Gavin Cull, Keith Fay, Geoff Chong, Andrew Grigg, Ian D Lewis, Sam Milliken, William Renwick, Uwe Hahn, Robin Filshie, George Kannourakis, Anne-Marie Watson, Pauline Warburton, et al.

Journal article  |  2017  |  Haematologica

Cardiac iron load and function in transfused patients treated with deferasirox (the MILE study)

P Joy Ho, Lay Tay, Juliana Teo, Paula Marlton, Andrew Grigg, Tim St Pierre, Greg Brown, Caro-Anne Badcock, Robert Traficante, Othon L Gervasio, Donald K Bowden

Journal article  |  2017  |  European Journal of Haematology

Is Upfront Escalated BEACOPP for Advanced Hodgkin Lymphoma Becoming a Distant Memory?

Eliza A Hawkes, Geoffrey Chong, Andrew Grigg

Journal article  |  2017  |  Journal of Clinical Oncology

Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea

Genevieve Douglas, Claire Harrison, Cecily Forsyth, Michael Bennett, William Stevenson, John Hounsell, Sumita Ratnasingam, David Ritchie, David M Ross, Andrew Grigg

Journal article  |  2017  |  Leukemia & Lymphoma

Limited Utility of Routine Chest X-Ray (CXR) in Initial Evaluation of Febrile Neutropenia in Patients with Haematological Diseases Undergoing Chemotherapy

Ortis Estacio, Zoe Loh, Andrew Grigg, Amy Baker, Leonid Churilov, Geoff Chong, Eliza A Hawkes

Conference Proceedings  |  2016  |  Blood

Patient Selection for High-Dose Methotrexate As Central Nervous System Prophylaxis in Diffuse Large B-Cell Lymphoma in Australia: Are We Getting It Right?

Melissa Garwood, Eliza A Hawkes, Leonid Churilov, Andrew Grigg, Geoff Chong

Conference Proceedings  |  2016  |  Blood

Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience

Wirawan Jeong, Peter Haywood, Naranie Shanmuganathan, Julian Lindsay, Karen Urbancic, Michelle R Ananda-Rajah, Sharon CA Chen, Ashish Bajel, David Ritchie, Andrew Grigg, John F Seymour, Anton Y Peleg, David CM Kong, Monica A Slavin

Journal article  |  2016  |  Journal of Antimicrobial Chemotherapy

Primary antifungal prophylaxis in adult patients with acute lymphoblastic leukaemia: a multicentre audit

Tan N Doan, Carl MJ Kirkpatrick, Patricia Walker, Monica A Slavin, Michelle R Ananda-Rajah, C Orla Morrissey, Karen F Urbancic, Andrew Grigg, Andrew Spencer, Jeffrey Szer, John F Seymour, David CM Kong

Journal article  |  2016  |  Journal of Antimicrobial Chemotherapy

Cellular Mechanisms Underlying Complete Hematological Response of Chronic Myeloid Leukemia to BRAF and MEK1/2 Inhibition in a Patient with Concomitant Metastatic Melanoma

Miles C Andrews, Natalie Turner, Janis Boyd, Andrew W Roberts, Andrew P Grigg, Andreas Behren, Jonathan Cebon

Journal article  |  2015  |  Clinical Cancer Research

Programmed cell death-1 inhibition in lymphoma

Eliza A Hawkes, Andrew Grigg, Geoff Chong

Journal article  |  2015  |  The Lancet Oncology

TIDEL-II: first-line use of imatinib in CML with early switch to nilotinib for failure to achieve time-dependent molecular targets

David T Yeung, Michael P Osborn, Deborah L White, Susan Branford, Jodi Braley, Alan Herschtal, Michael Kornhauser, Samar Issa, Devendra K Hiwase, Mark Hertzberg, Anthony P Schwarer, Robin Filshie, Christopher K Arthur, Yiu Lam Kwan, Judith Trotman, Cecily J Forsyth, John Taper, David M Ross, Jennifer Beresford, Constantine Tam, et al.

Journal article  |  2015  |  Blood

The oral iron chelator deferasirox inhibits NF-kappa B mediated gene expression without impacting on proximal activation: implications for myelodysplasia and aplastic anaemia

Ashish Banerjee, Nicole A Mifsud, Robert Bird, Cecily Forsyth, Jeff Szer, Constantine Tam, Sybil Kellner, Andrew Grigg, Penelope Motum, Mark Bentley, Stephen Opat, George Grigoriadis

Journal article  |  2015  |  British Journal of Haematology

Invasive fungal infections in patients with multiple myeloma: a multi-center study in the era of novel myeloma therapies

Benjamin W Teh, Jasmine C Teng, Karin Urbancic, Andrew Grigg, Simon J Harrison, Leon J Worth, Monica A Slavin, Karin A Thursky

Journal article  |  2015  |  Haematologica

Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014

CO Morrissey, NM Gilroy, N Macesic, P Walker, M Ananda-Rajah, M May, CH Heath, A Grigg, PG Bardy, J Kwan, SW Kirsa, M Slavin, T Gottlieb, S Chen

Journal article  |  2014  |  Internal Medicine Journal

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014

S Fleming, CK Yannakou, GM Haeusler, J Clark, A Grigg, CH Heath, A Bajel, SJ van Hal, SC Chen, ST Milliken, CO Morrissey, CS Tam, J Szer, R Weinkove, MA Slavin

Journal article  |  2014  |  Internal Medicine Journal

Primary breast lymphoma

Chan Y Cheah, Belinda A Campbell, John F Seymour

Journal article  |  2014  |  Cancer Treatment Reviews

Prognosis for patients with CML and > 10% BCR-ABL1 after 3 months of imatinib depends on the rate of BCR-ABL1 decline

Susan Branford, David T Yeung, Wendy T Parker, Nicola D Roberts, Leanne Purins, Jodi A Braley, Haley K Altamura, Alexandra L Yeoman, Jasmina Georgievski, Bronte A Jamison, Stuart Phillis, Zoe Donaldson, Mary Leong, Linda Fletcher, John F Seymour, Andrew P Grigg, David M Ross, Timothy P Hughes

Journal article  |  2014  |  Blood

Autologous Is Superior to Allogeneic Hematopoietic Cell Transplantation for Acute Promyelocytic Leukemia in Second Complete Remission

Jennifer L Holter Chakrabarty, Morel Rubinger, Jennifer Le-Rademacher, Hai-Lin Wang, Andrew Grigg, George B Selby, Jeffrey Szer, Jacob M Rowe, Daniel J Weisdorf, Martin S Tallman

Journal article  |  2014  |  Biology of Blood and Marrow Transplantation

Thrombopoietin receptor agonists in immune thrombocytopenia of less than 6 months duration

A Arumugaswamy, S He, H Quach, J Brotchie, A Grigg

Journal article  |  2014  |  Internal Medicine Journal

Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyurea.

Emma Verner, Cecily Forsyth, Andrew Grigg

Journal article  |  2014  |  Leukemia and Lymphoma

Abstract Cyclical thrombocytosis, acquired von Willebrand syndrome, aggressive non-melanoma skin cancers and other hydroxyurea com..

Dual epigenetic targeting with panobinostat and azacitidine in acute myeloid leukemia and high-risk myelodysplastic syndrome

P Tan, A Wei, S Mithraprabhu, N Cummings, HB Liu, M Perugini, K Reed, S Avery, S Patil, P Walker, P Mollee, A Grigg, R D'Andrea, A Dear, A Spencer

Journal article  |  2014  |  Blood Cancer Journal

Rituximab is associated with improved survival for aggressive B cell CNS lymphoma

Gareth Gregory, Ashwini Arumugaswamy, Teresa Leung, Kah-Lok Chan, Melody Abikhair, Constantine Tam, Ashish Bajel, Lawrence Cher, Andrew Grigg, David Ritchie, Stephen Opat

Journal article  |  2013  |  Neuro-Oncology

Central nervous system multiple myeloma - potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains

Denise Lee, Anna Kalff, Michael Low, Shane Gangatharan, Prahlad Ho, Ashish Bajel, David Ritchie, Andrew Grigg, Andrew Spencer

Journal article  |  2013  |  British Journal of Haematology

Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study

David M Ross, Susan Branford, John F Seymour, Anthony P Schwarer, Christopher Arthur, David T Yeung, Dang Phuong, Jarrad M Goyne, Cassandra Slader, Robin J Filshie, Anthony K Mills, Junia V Melo, Deborah L White, Andrew P Grigg, Timothy P Hughes

Journal article  |  2013  |  Blood

Pharmacoeconomic evaluation of fluconazole, posaconazole and voriconazole for antifungal prophylaxis in patients with acute myeloid leukaemia undergoing first consolidation chemotherapy

Siow-Chin Heng, Monica A Slavin, Daoud Al-Badriyeh, Sue Kirsa, John F Seymour, Andrew Grigg, Karin Thursky, Ashish Bajel, Roger L Nation, David CM Kong

Journal article  |  2013  |  Journal of Antimicrobial Chemotherapy

The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts

Camille Abboud, Ellin Berman, Adam Cohen, Jorge Cortes, Daniel DeAngelo, Michael Deininger, Steven Devine, Brian Druker, Amir Fathi, Elias Jabbour, Madan Jagasia, Hagop Kantarjian, Jean Khoury, Pierre Laneuville, Richard Larson, Jeffrey Lipton, Joseph O Moore, Tariq Mughal, Susan O'Brien, Javier Pinilla-Ibarz, et al.

Journal article  |  2013  |  Blood

IL15 levels on day 7 after hematopoietic cell transplantation predict chronic GVHD

LM Pratt, Y Liu, A Ugarte-Torres, M Hoegh-Petersen, PJ Podgorny, AW Lyon, TS Williamson, FM Khan, MA Chaudhry, A Daly, DA Stewart, JA Russell, A Grigg, D Ritchie, J Storek

Journal article  |  2013  |  Bone Marrow Transplantation

Making sense of posaconazole therapeutic drug monitoring: a practical approach

Michelle R Ananda-Rajah, Andrew Grigg, Monica A Slavin

Journal article  |  2012  |  Current Opinion in Infectious Diseases

All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)

Harry J Iland, Ken Bradstock, Shane G Supple, Alberto Catalano, Marnie Collins, Mark Hertzberg, Peter Browett, Andrew Grigg, Frank Firkin, Amanda Hugman, John Reynolds, Juliana Di Iulio, Campbell Tiley, Kerry Taylor, Robin Filshie, Michael Seldon, John Taper, Jeff Szer, John Moore, John Bashford, et al.

Journal article  |  2012  |  Blood

Impact of palifermin on mucosal toxicity in autologous stem cell transplants using busulfan-melphalan conditioning chemotherapy for Hodgkin and non-Hodgkin lymphoma

Philip Campbell, Adam Friebe, Paul Foulstone, Andrew Grigg, Jennifer Hempton, Ashish Bajel

Journal article  |  2012  |  Leukemia & Lymphoma

Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropenia

Prahlad Ho, Peter Sherman, Andrew Grigg

Journal article  |  2012  |  European Journal of Haematology

Comparative clinical effectiveness of prophylactic voriconazole/posaconazole to fluconazole/itraconazole in patients with acute myeloid leukemia/myelodysplastic syndrome undergoing cytotoxic chemotherapy over a 12-year period

Michelle R Ananda-Rajah, Andrew Grigg, Maria T Downey, Ashish Bajel, Tim Spelman, Allen Cheng, Karin T Thursky, Janette Vincent, Monica A Slavin

Journal article  |  2012  |  Haematologica

Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia

Harry Iland, Ken Bradstock, John Seymour, Mark Hertzberg, Andrew Grigg, Kerry Taylor, John Catalano, Paul Cannell, Noemi Horvath, Sandra Deveridge, Peter Browett, Tim Brighton, Li Chong, Francisca Springall, Juliet Ayling, Alberto Catalano, Shane Supple, Marnie Collins, Juliana Di Iulio, John Reynolds

Journal article  |  2012  |  Haematologica

CsA 2-h concentration correlates best with area under the concentration-time curve after allo-SCT compared with trough CsA

DCM Kong, P Shuttleworth, M Bailey, A Grigg

Journal article  |  2012  |  Bone Marrow Transplantation

Improved survival for relapsed diffuse large B cell lymphoma is predicted by a negative pre-transplant FDG-PET scan following salvage chemotherapy

Michael Dickinson, Rosemary Hoyt, Andrew W Roberts, Andrew Grigg, John F Seymour, H Miles Prince, Jeff Szer, David Ritchie

Journal article  |  2010  |  British Journal of Haematology

Pharmacoeconomic evaluation of voriconazole versus posaconazole for antifungal prophylaxis in acute myeloid leukaemia

Daoud Al-Badriyeh, Monica Slavin, Danny Liew, Karin Thursky, Maria Downey, Andrew Grigg, Ashish Bajel, Kay Stewart, David CM Kong

Journal article  |  2010  |  Journal of Antimicrobial Chemotherapy

Phase II study of autologous stem cell transplant using busulfan-melphalan chemotherapy-only conditioning followed by interferon for relapsed poor prognosis follicular non-Hodgkin lymphoma

Andrew P Grigg, Janey Stone, Alvin D Milner, Anthony P Schwarer, Max Wolf, H Miles Prince, John Seymour, Devinder Gill, David Ellis, John Bashford

Journal article  |  2010  |  Leukemia and Lymphoma

Comparative PET study using F-18 FET and F-18 FDG for the evaluation of patients with suspected brain tumour

Eddie WF Lau, Katharine J Drummond, Robert E Ware, Elizabeth Drummond, Annette Hogg, Gail Ryan, Andrew Grigg, Jason Callahan, Rodney J Hicks

Journal article  |  2010  |  Journal of Clinical Neuroscience

The BH3 mimetic compound, ABT-737, synergizes with a range of cytotoxic chemotherapy agents in chronic lymphocytic leukemia

KD Mason, SL Khaw, KC Rayeroux, E Chew, EF Lee, WD Fairlie, AP Grigg, JF Seymour, J Szer, DCS Huang, AW Roberts

Journal article  |  2009  |  Leukemia

Surgical Management of Invasive Pulmonary Fungal Infection in Hematology Patients

Sanjay Theodore, Matthew Liava'a, Phillip Antippa, Rochelle Wynne, Andrew Grigg, Monica Slavin, James Tatoulis, Douglas E Wood

Journal article  |  2009  |  Annals of Thoracic Surgery

Impact of early dose intensity on cytogenetic and molecular responses in chronic-phase CML patients receiving 600 mg/day of imatinib as initial therapy

Timothy P Hughes, Susan Branford, Deborah L White, John Reynolds, Rachel Koelmeyer, John F Seymour, Kerry Taylor, Chris Arthur, Anthony Schwarer, James Morton, Julian Cooney, Michael F Leahy, Philip Rowlings, John Catalano, Mark Hertzberg, Robin Filshie, Anthony K Mills, Keith Fay, Simon Durrant, Henry Januszewicz, et al.

Journal article  |  2008  |  Blood

A multicenter prospective phase 2 randomized study of extracorporeal photopheresis for treatment of chronic graft-versus-host disease

Mary ED Flowers, Jane F Apperley, Koen van Besien, Ahmet Elmaagacli, Andrew Grigg, Vijay Reddy, Andrea Bacigalupo, Hans-Jochem Kolb, Luis Bouzas, Mauricette Michallet, H Miles Prince, Robert Knobler, Dennis Parenti, Jose Gallo, Hildegard T Greinix

Journal article  |  2008  |  Blood

Gram-negative organisms predominate in Hickman line-related infections in non-neutropenic patients with hematological malignancies

L Chee, M Brown, J Sasadeusz, L MacGregor, AP Grigg

Journal article  |  2008  |  Journal of Infection

Cyclosporin, methotrexate and prednisolone for graft-versus-host disease prophylaxis in allogeneic peripheral blood progenitor cell transplants

R Hoyt, DS Ritchie, AW Roberts, L MacGregor, DJ Curtis, J Szer, AP Grigg

Journal article  |  2008  |  Bone Marrow Transplantation

BCR-ABL messenger RNA levels continue to decline in patients with chronic phase chronic myeloid leukemia treated with imatinib for more than 5 years and approximately half of all first-line treated patients have stable undetectable BCR-ABL using strict sensitivity criteria

Susan Branford, John F Seymour, Andrew Grigg, Chris Arthur, Zbigniew Rudzki, Kevin Lynch, Timothy Hughes

Journal article  |  2007  |  Clinical Cancer Research

A randomized comparison of empiric or pre-emptive antibiotic therapy after hematopoietic stem cell transplantation

MA Slavin, AP Grigg, AP Schwarer, J Szer, A Spencer, A Sainani, KA Thursky, AW Roberts

Journal article  |  2007  |  Bone Marrow Transplantation

A prospective multicenter trial of peripheral blood stem cell sibling allografts for acute myeloid leukemia in first complete remission using fludarabine-cyclophosphamide reduced intensity conditioning

AP Grigg, J Gibson, PG Bardy, J Reynolds, P Shuttleworth, RL Koelmeyer, J Szer, AW Roberts, LB To, G Kennedy, KF Bradstock

Journal article  |  2007  |  Biology of Blood and Marrow Transplantation

Effect of hydroxyurea on sperm count, motility and morphology in adult men with sickle cell or myeloproliferative disease

A Grigg

Journal article  |  2007  |  Internal Medicine Journal

The hyper-CVAD-rituximab chemotherapy programme followed by high-dose busulfan, melphalan and autologous stem cell transplantation produces excellent event-free survival in patients with previously untreated mantle cell lymphoma

DS Ritchie, JF Seymour, AP Grigg, AW Roberts, R Hoyt, S Thompson, J Szer, HM Prince

Journal article  |  2007  |  Annals of Hematology

Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma

Simon He, Andrew Roberts, David Ritchie, Andrew Grigg

Journal article  |  2007  |  Leukemia and Lymphoma

Female genital tract graft-versus-host disease: incidence, risk factors and recommendations for management

D Zantomio, AP Grigg, L MacGregor, Y Panek-Hudson, J Szer, R Ayton

Journal article  |  2006  |  Bone Marrow Transplantation

Pamidronate Reduces Bone Loss after Allogeneic Stem Cell Transplantation

AP Grigg, P Shuttleworth, J Reynolds, AP Schwarer, J Szer, K Bradstock, C Hui, R Herrmann, PR Ebeling

Journal article  |  2006  |  Journal of Clinical Endocrinology & Metabolism

Zoledronic acid prevents bone loss after allogeneic haemopoietic stem cell transplantation

AB D'Souza, AP Grigg, J Szer, PR Ebeling

Journal article  |  2006  |  Internal Medicine Journal

Genetic heterogeneity of granulocytes for the JAK2 V617F mutation in essential thrombocythaemia: Implications for mutation detection in peripheral blood

William S Stevenson, Rosemary Hoyt, Anthony Bell, Michel Guipponi, Surender Juneja, Andrew P Grigg, David J Curtis, Hamish S Scott, Jeff Szer, Warren S Alexander, Annabel Tuckfield, Andrew W Roberts

Journal article  |  2006  |  Pathology

Allogeneic stem cell transplantation with peripheral blood stem cells mobilized by pegylated G-CSF

Geoffrey R Hill, Edward S Morris, Madonna Fuery, Cheyl Hutchins, Jason Butler, Andrew Grigg, Andrew Roberts, Ken Bradstock, Jeffrey Szer, Glen Kennedy, James Morton, Simon Durrant

Journal article  |  2006  |  Biology of Blood and Marrow Transplantation

Cerebral vaso-occlusive event with low-osmolar intravenous contrast in a patient with sickle cell disease

D Zantomio, RJ Dowling, A Grigg

Journal article  |  2006  |  American Journal of Hematology

Reduced-intensity allogeneic haemopoietic stem cell transplantation induces durable responses in patients with chronic B-lymphoproliferative disorders

M Hertzberg, A Grigg, D Gottlieb, J Szer, A Roberts, R Hoyt, G Huang, KF Bradstock

Journal article  |  2006  |  Bone Marrow Transplantation

Correlation of T-cell immune response with spontaneous resolution and subsequent relapse of Hodgkin's lymphoma

WM Wilson, U Dua, AP Grigg, MK Gandhi

Journal article  |  2006  |  Leukemia and Lymphoma

Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield

T Seshadri, D Gook, S Lade, A Spencer, A Grigg, K Tiedemann, J McKendrick, P Mitchell, C Stern, JF Seymour

Journal article  |  2006  |  British Journal of Cancer

PET positive progressive transformation of germinal centers masquerading as relapsed Hodgkin lymphoma post-autograft

A Grigg, V Ganju

Journal article  |  2006  |  Leukemia and Lymphoma

Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate

N Murphy, M Diviney, J Szer, P Bardy, A Grigg, R Hoyt, B King, L MacGregor, R Holdsworth, J McCluskey, BD Tait

Journal article  |  2006  |  Bone Marrow Transplantation

More on Myb in myelofibrosis: molecular analyses of MYB and EP300 in 55 patients with myeloproliferative disorders

DP Steensma, A Pardanani

Journal article  |  2006  |  Blood

Daclizumab in anaplastic large cell lymphoma

A Grigg

Journal article  |  2006  |  Leukemia and Lymphoma

Passive donor-to-recipient transfer of anti phospholipid syndrome following allogeneic stem-cell transplantation

DS Ritchie, A Sainani, A D'Souza, AP Grigg

Journal article  |  2005  |  American Journal of Hematology

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia

CN Harrison, PJ Campbell, G Buck, K Wheatley, CL East, D Bareford, BS Wilkins, JD van der Walt, JT Reilly, AP Grigg, P Revell, BE Woodcock, AR Green, TC Pearson, E Conneally, C Crawley, NCP Cross, G Hall, B Hunt, G Lucas, et al.

Journal article  |  2005  |  New England Journal of Medicine

Autografting followed by rituximab for chemosensitive mantle cell lymphoma: A pilot study and literature review

AP Grigg, J Bashford, JF Seymour, P Shuttleworth, D Norris, M Hertzberg, D Gill, M Waugh, R Saal, P Marlton

Journal article  |  2005  |  Leukemia and Lymphoma

Early and late infectious consequences of adding rituximab to fludarabine and cyclophosphamide in patients with indolent lymphoid malignancies

CS Tam, JF Seymour, M Brown, P Campbell, J Scarlett, C Underhill, D Ritchie, R Bond, AP Grigg

Journal article  |  2005  |  Haematologica

A new model for predicting infectious complications during fludarabine-based combination chemotherapy among patients with indolent lymphoid malignancies

CS Tam, MM Wolf, EH Januszewicz, AP Grigg, HM Prince, D Westerman, JF Seymour

Journal article  |  2004  |  Cancer

Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase

S Branford, Z Rudzki, A Harper, A Grigg, K Taylor, S Durrant, C Arthur, P Browett, AP Schwarer, D Ma, JF Seymour, K Bradstock, D Joske, K Lynch, I Gathmann, TP Hughes

Journal article  |  2003  |  Leukemia

Primary adrenal lymphoma

AP Grigg, JM Connors

Journal article  |  2003  |  Clinical Lymphoma

Esophageal perforation secondary to angio-invasive Candida glabrata following hemopoietic stem cell transplantation

HAM Tran, JM Vincent, MA Slavin, A Grigg

Journal article  |  2003  |  Clinical Microbiology and Infection

Prolonged molecular remission after arsenic trioxide and all-trans retinoic acid for acute promyelocytic leukemia relapsed after allogeneic stem cell transplantation

A Grigg, R Kimber, J Szer

Journal article  |  2003  |  Leukemia

Multicenter phase 2 trial of thalidomide in relapsed/refractory multiple myeloma: adverse prognostic impact of advanced age

L Mileshkin, JJ Biagi, P Mitchell, C Underhill, A Grigg, R Bell, J McKendrick, P Briggs, JF Seymour, K Lillie, JG Smith, JB Zeldis, HM Prince

Journal article  |  2003  |  Blood

Graft-versus-host disease, donor chimerism, and organ toxicity in stem cell transplantation after conditioning with fludarabine and melphalan

DS Ritchie, J Morton, J Szer, AW Roberts, S Durrant, P Shutttleworth, AP Grigg

Journal article  |  2003  |  Biology of Blood and Marrow Transplantation

Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis

S Branford, Z Rudzki, S Walsh, I Parkinson, A Grigg, J Szer, K Taylor, R Herrmann, JF Seymour, C Arthur, D Joske, K Lynch, T Hughes

Journal article  |  2003  |  Blood

Delayed-onset neutropenia associated with rituximab therapy

K Chaiwatanatorn, N Lee, A Grigg, R Filshie, F Firkin

Journal article  |  2003  |  British Journal of Haematology

T-cell depletion does not necessarily compromise donor stem cell engraftment in patients receiving reduced-intensity conditioning regimens

C Craddock, AP Grigg

Journal article  |  2003  |  Bone Marrow Transplantation

Successful peripheral blood stem cell mobilisation with filgrastim in patients with chronic myeloid leukaemia achieving complete cytogenetic response with imatinib, without increasing disease burden as measured by quantitative real-time PCR

CH Hui, KY Goh, D White, S Branford, A Grigg, JF Seymour, YL Kwan, S Walsh, R Hoyt, A Trickett, B Rudzki, DDF Ma, LB To, TP Hughes

Journal article  |  2003  |  Leukemia

Morphological effects of imatinib mesylate (STI571) on the bone marrow and blood of patients with Philadelphia chromosome (Ph) positive chronic myeloid leukaemia

C McNamara, A Grigg, J Szer, A Roberts, L Campbell, R Hoyt, K Lynch, S Juneja

Journal article  |  2003  |  Clinical and Laboratory Haematology

The incidence, pathogenesis and natural history of steatorrhoea after bone marrow transplantation

AP Grigg, PW Angus, R Hoyt, J Szer

Journal article  |  2003  |  Bone Marrow Transplantation

A phase I dose-escalation study of etoposide continuous infusion added to busulphan/cyclophosphamide as conditioning prior to autologous or allogeneic stem cell transplantation

DS Ritchie, J Szer, AW Roberts, P Shuttleworth, AP Grigg

Journal article  |  2002  |  Bone Marrow Transplantation

Portal or hepatic vein thrombosis as the first presentation of a myeloproliferative disorder in patients with normal peripheral blood counts

C McNamara, S Juneja, M Wolf, A Grigg

Journal article  |  2002  |  Clinical and Laboratory Haematology

Prospects for stem cell transplantation in multiple sclerosis

TJ Kilpatrick, H Butzkueven, A Grigg

Journal article  |  2002  |  Journal of Clinical Neuroscience

Aplastic anemia as a late complication of thymoma in remission

DS Ritchie, C Underhill, AP Grigg

Journal article  |  2002  |  European Journal of Haematology

Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation

CG Mullighan, S Heatley, K Doherty, F Szabo, A Grigg, TP Hughes, AP Schwarer, J Szer, BD Tait, LB To, PG Bardy

Journal article  |  2002  |  Blood